BeOne Medicines Ltd. (ONC) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2014: $654.0K2015: $5.31M2016: $23.50M2017: $46.37M2018: $70.28M2019: $89.61M2020: $117.51M2021: $262.94M2022: $325.43M2023: $561.90M2024: $492.66M2025: $185.84M$185.84M
2014Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$185.84M-62.3%
2024$492.66M-12.3%
2023$561.90M+72.7%
2022$325.43M+23.8%
2021$262.94M+123.8%
2020$117.51M+31.1%
2019$89.61M+27.5%
2018$70.28M+51.6%
2017$46.37M+97.3%
2016$23.50M+342.3%
2015$5.31M+712.5%
2014$654.0K